Recovery	recovery	O	O	O	O
of	of	O	O	O	O
tacrolimus-associated	tacrolimus-associated	O	O	O	O
brachial	brachial	O	O	OTHERS	I
neuritis	neuritis	O	O	OTHERS	I
after	after	O	O	O	O
conversion	conversion	O	O	O	O
to	to	O	O	O	O
everolimus	everolimus	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
pediatric	pediatric	O	O	O	O
renal	renal	O	O	O	O
transplant	transplant	O	O	O	O
recipient	recipient	O	O	O	O
--	--	O	O	O	O
case	case	O	O	O	O
report	report	O	O	O	O
and	and	O	O	O	O
review	review	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
literature	literature	O	O	O	O
.	.	O	O	O	O

TAC	tac	CHEMICALS	O	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
shown	shown	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
a	a	O	O	O	O
potent	potent	O	O	O	O
immunosuppressive	immunosuppressive	O	O	O	O
agent	agent	O	O	O	O
for	for	O	O	O	O
solid	solid	O	O	O	O
organ	organ	O	O	O	O
transplantation	transplantation	O	O	O	O
in	in	O	O	O	O
pediatrics	pediatrics	O	O	O	O
.	.	O	O	O	O

Neurotoxicity	neurotoxicity	O	DISEASE	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
potentially	potentially	O	O	O	O
serious	serious	O	O	O	O
toxic	toxic	O	O	O	O
effect	effect	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
characterized	characterized	O	O	O	O
by	by	O	O	O	O
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
headaches	headaches	O	O	OTHERS	I
,	,	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
,	,	O	O	O	O
or	or	O	O	O	O
neurological	neurological	O	O	OTHERS	I
deficits	deficits	O	O	OTHERS	I
.	.	O	O	O	O

Here	here	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
describe	describe	O	O	O	O
an	an	O	O	O	O
eight-and-a-half-yr-old	eight-and-a-half-yr-old	O	O	O	O
male	male	O	O	O	O
renal	renal	O	O	O	O
transplant	transplant	O	O	O	O
recipient	recipient	O	O	O	O
with	with	O	O	O	O
right	right	O	O	O	O
BN	bn	O	O	O	O
.	.	O	O	O	O

MRI	mri	O	O	O	O
demonstrated	demonstrated	O	O	O	O
hyperintense	hyperintense	O	O	O	O
T2	t2	O	O	O	O
signals	signals	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
cervical	cervical	O	O	O	O
cord	cord	O	O	O	O
and	and	O	O	O	O
right	right	O	O	O	O
brachial	brachial	O	O	O	O
plexus	plexus	O	O	O	O
roots	roots	O	O	O	O
indicative	indicative	O	O	O	O
of	of	O	O	O	O
both	both	O	O	O	O
myelitis	myelitis	O	O	OTHERS	I
and	and	O	O	O	O
right	right	O	O	O	O
brachial	brachial	O	O	OTHERS	I
plexitis	plexitis	O	O	OTHERS	I
.	.	O	O	O	O

Symptoms	symptoms	O	O	O	O
persisted	persisted	O	O	O	O
for	for	O	O	O	O
three	three	O	O	O	O
months	months	O	O	O	O
despite	despite	O	O	O	O
TAC	tac	CHEMICALS	O	OTHERS	I
dose	dose	O	O	O	O
reduction	reduction	O	O	O	O
,	,	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
IVIG	ivig	O	O	O	O
and	and	O	O	O	O
four	four	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
methylprednisolone	methylprednisolone	CHEMICALS	O	OTHERS	I
pulse	pulse	O	O	O	O
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Improvement	improvement	O	O	O	O
and	and	O	O	O	O
eventually	eventually	O	O	O	O
full	full	O	O	O	O
recovery	recovery	O	O	O	O
only	only	O	O	O	O
occurred	occurred	O	O	O	O
after	after	O	O	O	O
TAC	tac	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
completely	completely	O	O	O	O
discontinued	discontinued	O	O	O	O
and	and	O	O	O	O
successfully	successfully	O	O	O	O
replaced	replaced	O	O	O	O
by	by	O	O	O	O
everolimus	everolimus	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

